COMP <GO>
NOVT vs JBTM // EV/EBITDA & P/E VALUATION
Novanta Inc. (NASDAQ) VS. JBT Marel Corporation (NYSE) • 15-METRIC TALLY: NOVT 9
— JBTM 5
▲ EV/EBITDA & P/E VALUATION LEADER: JBTM
LAST: $146.24 (+0.33%) • MKT CAP: $5.51B
valuation
51.7x
LAST: $114.78 (+5.14%) • MKT CAP: $5.66B
valuation
21.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NOVT VS. JBTM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NOVT | JBTM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.40% | 35.10% | +9.30 | NOVT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.50% | 2.60% | +3.90 | NOVT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 51.7x | 21.0x | +30.70 | JBTM | /valuation <GO> |
| Free Cash Flow Yield | 0.85% | -3.99% | +4.84 | NOVT | /fcf-yield <GO> |
| Operating Margin | 9.60% | 5.00% | +4.60 | NOVT | /operating-margins <GO> |
| Net Profit Margin | 5.50% | -1.30% | +6.80 | NOVT | /net-margins <GO> |
| Revenue Growth (YoY) | 3.30% | 121.30% | -118.00 | JBTM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.36% | -0.36 | JBTM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.30 | 1.66 | +6.64 | NOVT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 3/9 | +4.00 | NOVT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 50.4 | +1.30 | NOVT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.99 | +0.02 | NOVT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 98.8x | 18.0x | +80.80 | JBTM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.51B | $5.66B | -$151.1M | JBTM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NOVT REV | JBTM REV | NOVT GROSS % | JBTM GROSS % | NOVT FCF | JBTM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $980.6M | $3.80B | 44.4% | 35.1% | $48.4M | — |
| FY 2024 | $949.2M | $1.72B | 44.4% | 36.5% | $141.3M | — |
| FY 2023 | $881.7M | $1.66B | — | — | $80.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NOVT // BETA 1.01
JBTM // BETA 0.99